BD Biosciences discuss implications of chemically defined media supplements
BD Biosciences have been exploring the total cost-in-use implications of a chemically defined process, in order to reduce costs by utilizing the most advanced chemically defined media supplement possible.
Find out how BD Biosciences have achieved this goal at the Cell Culture World Congress 2012 where Dr Samuel Denby, Applications and Scientific Manager will be presenting their strategies to overcoming this limitation;
- Evaluating qualitatively the potential benefit of chemically defined manufacturing processes
- Understand how the next generation chemically defined supplements offer a route to maintain high productivity levels, with peptone supplements, while gaining the advantages of a chemically defined manufacturing process
- Explore quantitatively how BD Rechargeâ„˘, one of these supplements, may impact cost of goods
Canâ€™t wait until 2012?
Uncover the strategies employed by BD Biosciences to develop the concepts behind their chemically defined media supplement by DOWNLOADING their whitepapers
Taking place on 28th, 29th February and 1st March 2012, the Cell Culture World Congress 2012 will bring together senior representatives from Boehringer Ingelheim, Merck Serono, Roche, Genzyme, Novartis and many more to present their latest advances in cull culture techniques.
I look forward to welcoming you to Munich in February.